Arkolith/Insider Trading/REPH/Form 4

Enloe J David JR

Chief Executive Officer, DirectorRecro Pharma, Inc. (REPH) · full profile →Form 4 · filed Dec 17, 2021
Net Buying
Open-Market Buys
$993
Open-Market Sells
$0
Net Open-Market Flow
$993
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 15, 2021Buy(P)617$1.61$993154K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-21-048870) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML